Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease

American Heart Journal

Volumn 155, Issue 2, 2008, Pages 356-360

  Stefanescu, Ada ^a   Braun, Siegmund ^b   Ndrepepa, Gjin ^b   Koppara, Tobias ^b   Pavaci, Herribert ^c   Mehilli, Julinda ^b   Schömig, Albert ^b,c   Kastrati, Adnan ^b  

^a MCGILL UNIVERSITY   (Canada)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; MYELOPEROXIDASE;

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL;

AGED; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 38349058207     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.10.017     Document Type: Article

References (27)

1. Shishehbor M.H., Aviles R.J., Brennan M.L., et al. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA 289 (2003) 1675-1680
2. Daugherty A., Dunn J.L., Rateri D.L., et al. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94 (1994) 437-444
3. Buffon A., Biasucci L.M., Liuzzo G., et al. Widespread coronary inflammation in unstable angina. N Engl J Med 347 (2002) 5-12
4. Zhang R., Brennan M.L., Fu X., et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286 (2001) 2136-2142
5. Brennan M.L., Penn M.S., Van Lente F., et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349 (2003) 1595-1604
6. Baldus S., Heeschen C., Meinertz T., et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108 (2003) 1440-1445
7. Mocatta T.J., Pilbrow A.P., Cameron V.A., et al. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 49 (2007) 1993-2000
8. Lau D., and Baldus S. Myeloperoxidase and its contributory role in inflammatory vascular disease. Pharmacol Ther 111 (2006) 16-26
9. Malle E., Marsche G., Panzenboeck U., et al. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins. Arch Biochem Biophys 445 (2006) 245-255
10. Zhang R., Brennan M.-L., Shen Z., et al. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 277 (2002) 46116-46122
11. Baldus S., Heitzer T., Eiserich J.P., et al. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med 37 (2004) 902-911
12. Tang W.W.H., Tong W., Troughton R.W., et al. Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure. J Am Coll Cardiol 49 (2007) 2364-2370
13. Meuwese M.C., Stroes E.S., Hazen S.L., et al. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk prospective population study. J Am Coll Cardiol 50 (2007) 159-165
14. Ben-Dor I., and Battler A. Treatment of stable angina. Heart 93 (2007) 868-874
15. Daly C.A., Clemens F., Sendon J.L.L., et al. The clinical characteristics and investigations planned in patients with stable angina presenting to cardiologists in Europe: from the Euro Heart Survey of stable angina. Eur Heart J 26 (2005) 996-1010
16. Abrams J. Clinical practice. Chronic stable angina. N Engl J Med 352 (2005) 2524-2533
17. Kragelund C., Gronning B., Kober L., et al. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352 (2005) 666-675
18. Ndrepepa G., Braun S., Niemöller K., et al. Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina. Circulation 112 (2005) 2102-2107
19. Dibra A., Mehilli J., Braun S., et al. Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med 114 (2003) 715-722
20. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus (1999), World Health Organization, Geneva
21. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
22. Naruko T., Ueda M., Haze K., et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106 (2002) 2894-2900
23. Sugiyama S., Okada Y., Sukhova G.K., et al. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 158 (2001) 879-891
24. Sugiyama S., Kugiyama K., Aikawa M., et al. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 24 (2004) 1309-1314
25. Cavusoglu E., Ruwende C., Eng C., et al. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Am J Cardiol 99 (2007) 1364-1368
26. Ndrepepa G., Braun S., Mehilli J., et al. Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes. Eur J Clin Invest (2007) [in press]
27. Hoy A., Trégouët D., Leininger-Muller B., et al. Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms. Eur J Hum Genet 9 (2001) 780-786